From January 1, 2024 to March 31, 2024, the company has repurchased 1,521,975 shares, representing 0.37% for CNY 23.86 million. With this, the company has completed the repurchase of 1,521,975 shares, representing 0.37% for CNY 23.86 million under the buyback announced on December 27, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.94 CNY | +1.77% |
|
-0.91% | -45.71% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.71% | 62Cr | |
+23.13% | 4.69TCr | |
+37.26% | 3.91TCr | |
-8.73% | 3.85TCr | |
+28.09% | 3.1TCr | |
-12.26% | 2.61TCr | |
+10.57% | 2.59TCr | |
+45.05% | 1.42TCr | |
+32.23% | 1.25TCr | |
-6.56% | 1.14TCr |
- Stock Market
- Equities
- 688046 Stock
- News GemPharmatech Co., Ltd.
- Tranche Update on GemPharmatech Co., Ltd.'s Equity Buyback Plan announced on December 27, 2023.